GLP1R and endometrial cancer: Apart from the meta-analyses described above that included gynecologic malignancies among multiple cancers (24, 26), evidence to support a role for GLP-1R therapies in lowering endometrial cancer risk or progression is limited to preclinical studies and corroboration of mechanisms in human specimens (76).